290 related articles for article (PubMed ID: 22011071)
41. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
[TBL] [Abstract][Full Text] [Related]
42. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
Li L; Tang F; Liu H; Liu T; Hao N; Chen D; Teng X; He J
ACS Nano; 2010 Nov; 4(11):6874-82. PubMed ID: 20973487
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer.
Cui FB; Li RT; Liu Q; Wu PY; Hu WJ; Yue GF; Ding H; Yu LX; Qian XP; Liu BR
Cancer Lett; 2014 Apr; 346(1):53-62. PubMed ID: 24333735
[TBL] [Abstract][Full Text] [Related]
44. Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles.
Akbarian A; Ebtekar M; Pakravan N; Hassan ZM
Int J Biol Macromol; 2020 Jun; 152():90-101. PubMed ID: 32057865
[TBL] [Abstract][Full Text] [Related]
45. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
46. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
47. In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.
Sreeranganathan M; Uthaman S; Sarmento B; Mohan CG; Park IK; Jayakumar R
Int J Nanomedicine; 2017; 12():7165-7182. PubMed ID: 29033568
[TBL] [Abstract][Full Text] [Related]
48. Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
Singh SK; Lillard JW; Singh R
Cancer Lett; 2018 Jul; 427():49-62. PubMed ID: 29678549
[TBL] [Abstract][Full Text] [Related]
49. Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for Docetaxel Targeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells.
Yang Z; Tang W; Luo X; Zhang X; Zhang C; Li H; Gao D; Luo H; Jiang Q; Liu J
J Biomed Nanotechnol; 2015 Aug; 11(8):1401-17. PubMed ID: 26295141
[TBL] [Abstract][Full Text] [Related]
50. Improving DNA double-strand repair inhibitor KU55933 therapeutic index in cancer radiotherapy using nanoparticle drug delivery.
Tian X; Lara H; Wagner KT; Saripalli S; Hyder SN; Foote M; Sethi M; Wang E; Caster JM; Zhang L; Wang AZ
Nanoscale; 2015 Dec; 7(47):20211-9. PubMed ID: 26575637
[TBL] [Abstract][Full Text] [Related]
51. Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy.
Yadav S; Gupta S
Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):93-102. PubMed ID: 24195582
[TBL] [Abstract][Full Text] [Related]
52. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines.
Banu H; Sethi DK; Edgar A; Sheriff A; Rayees N; Renuka N; Faheem SM; Premkumar K; Vasanthakumar G
J Photochem Photobiol B; 2015 Aug; 149():116-28. PubMed ID: 26057021
[TBL] [Abstract][Full Text] [Related]
53. Targeted Nanoparticles for Fluorescence Imaging of Folate Receptor Positive Tumors.
Marko AJ; Borah BM; Siters KE; Missert JR; Gupta A; Pera P; Isaac-Lam MF; Pandey RK
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33317162
[TBL] [Abstract][Full Text] [Related]
54. Rational design of cancer-targeted BSA protein nanoparticles as radiosensitizer to overcome cancer radioresistance.
Huang Y; Luo Y; Zheng W; Chen T
ACS Appl Mater Interfaces; 2014; 6(21):19217-28. PubMed ID: 25314331
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticle formulation of small DNA molecules, Dbait, improves the sensitivity of hormone-independent prostate cancer to radiotherapy.
Yao H; Qiu H; Shao Z; Wang G; Wang J; Yao Y; Xin Y; Zhou M; Wang AZ; Zhang L
Nanomedicine; 2016 Nov; 12(8):2261-2271. PubMed ID: 27389144
[TBL] [Abstract][Full Text] [Related]
56. Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
Zhai G; Wu J; Xiang G; Mao W; Yu B; Li H; Piao L; Lee LJ; Lee RJ
J Nanosci Nanotechnol; 2009 Mar; 9(3):2155-61. PubMed ID: 19435095
[TBL] [Abstract][Full Text] [Related]
57. Radiosensitization of colon cancer cell lines by docetaxel: mechanisms of action.
Dunne AL; Mothersill C; Robson T; Wilson GD; Hirst DG
Oncol Res; 2004; 14(9):447-54. PubMed ID: 15490976
[TBL] [Abstract][Full Text] [Related]
58. Boosting the therapeutic efficacy of discoidal nanoconstructs against glioblastoma with rationally designed PEG-Docetaxel conjugates.
Felici A; Schlich M; Di Mascolo D; Goldoni L; Lisa Palange A; Decuzzi P
Eur J Pharm Biopharm; 2022 May; 174():90-100. PubMed ID: 35358697
[TBL] [Abstract][Full Text] [Related]
59. Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.
Pan D; Schmieder AH; Wang K; Yang X; Senpan A; Cui G; Killgore K; Kim B; Allen JS; Zhang H; Caruthers SD; Shen B; Wickline SA; Lanza GM
Theranostics; 2014; 4(6):565-78. PubMed ID: 24723979
[TBL] [Abstract][Full Text] [Related]
60. Targeted Delivery of Cabazitaxel by Conjugation to Albumin-PEG-folate Nanoparticles Using a Cysteine-acrylate Linker and Simple Synthesis Conditions.
Khoeeniha MK; Esfandyari-Manesh M; Behrouz H; Amini M; Varnamkhasti BS; Atyabi F; Dinarvand R
Curr Drug Deliv; 2017; 14(8):1120-1129. PubMed ID: 27875950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
